Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Vertex Pharmaceuticals has agreed to acquire Semma Therapeutics, a privately held biotechnology company specializing in Type 1 diabetes treatments, for $950 million in cash. Semma has developed a therapeutic approach to address the causal human...